Going Concern (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Jan. 28, 2021 |
Jan. 31, 2021 |
Oct. 31, 2020 |
Jul. 31, 2020 |
Jan. 31, 2020 |
Oct. 31, 2019 |
Jul. 31, 2019 |
Jan. 31, 2021 |
Jan. 31, 2020 |
Apr. 30, 2020 |
|
Cash | $ 13,992,772 | $ 13,992,772 | $ 2,749,957 | |||||||
Working capital | 14,000,000 | 14,000,000 | ||||||||
Accumulated deficit | (41,090,318) | (41,090,318) | $ (31,587,952) | |||||||
Net loss | $ (3,700,580) | $ (4,844,666) | $ (957,120) | $ (961,458) | $ (2,227,086) | $ (1,308,599) | (9,502,366) | $ (4,497,143) | ||
Cash used in operating activities | (6,365,362) | (3,551,402) | ||||||||
Proceeds from issuance of private placement | $ 8,371,167 | |||||||||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | |||||||
Additional paid in capital | $ 71,816,386 | $ 71,816,386 | $ 41,093,050 | |||||||
Purchase Agreement [Member] | Accredited Investors [Member] | ||||||||||
Number of common stock issued for sale | 914,136 | |||||||||
Common stock at per share | $ 10.54 | |||||||||
Purchase Agreement [Member] | Accredited Investors [Member] | Private Placement [Member] | ||||||||||
Number of warrats issued | 457,068 | |||||||||
Exercise price of warrants | $ 14.50 | |||||||||
Proceeds from issuance of private placement | $ 9,600,000 | |||||||||
Subscription Agreements [Member] | ||||||||||
Common stock, shares to be issued | 794,136 | 794,136 | ||||||||
Common stock, par value | $ 794 | $ 794 | ||||||||
Additional paid in capital | $ 8,370,373 | $ 8,370,373 |
X | ||||||||||
- Definition Common stock, shares to be issued. No definition available.
|
X | ||||||||||
- Definition Working capital. No definition available.
|
X | ||||||||||
- Definition Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|